YOLFTbeta
Applied BioCode

Applied BioCode

6598 · TW · Healthcare / Medical Devices

24.80TWD+0.20 (+0.81%)

Price History

Full chart

Market Stats

Previous Close24.60
Open24.65
Day Range24.65 – 24.95
52-Week Range20.50 – 31.90
Volume75.33K
Market Cap2.80B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.48
Dividend Yield0.00%
Beta0.63
50-Day Avg28.32
200-Day Avg24.93

About

Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. Its products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the detection steps, PCR amplification, and hybridization and target capture; and the BioCode 2500 analyzer, a system that reads each barcode and quantifies the BMB target using the fluorescence signal intensity. The company develops assays, such as BioCode SARS-CoV-2 Assay, an assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products. In addition, it provides BioCode Fungal Panel, a multiplexed deoxyribonucleic acid (DNA) amplification test; and BioCode STI + Resistance Panel (RUO), a multiplex nucleic acid amplification test. Further, the company offers barcoded magnetic bead accessories. Applied BioCode Corporation was founded in 2016 and is based in Grand Cayman, the Cayman Islands.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Winston Z. Ho Ph.D.
  • Employees0
  • HeadquartersGrand Pavilion, Hibiscus Way, Grand Cayman, Cayman Islands, KY1-1205, Taiwan
  • Websitehttps://www.apbiocode.com

Leadership

  • Dr. Winston Z. Ho Ph.D.Founder, CEO, President & Director
  • Mr. Jaca Liang-Kai HuangCFO & Corporate Governance Officer
  • Dr. Beth Laderman Ph.D.Chief Scientific Officer
  • Ms. Parisa Hanachi Ph.D.Vice President of Marketing
  • Mr. Jim LeighSenior Vice President of Sales
  • Zhao Gu ChenAccounting Director
  • Yu-Tsung ChouChief Information Officer
  • Ms. Ruei-E TangAdministration Division Director
  • Ms. Ingrid JosephAdministration Division Director

Financials

Income Statement

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue26.62M15.19M23.25M11.76M26.76M37.15M104.69M299.01M319.96M390.30M395.17M343.07M475.20M
Growth (%)--42.95%+53.08%-49.42%+127.52%+38.83%+181.85%+185.61%+7.01%+21.98%+1.25%-13.18%+38.52%
Cost of Revenue24.60M12.46M17.01M6.87M17.84M20.41M51.73M105.49M130.59M156.13M126.43M139.07M214.31M
Gross Profit2.02M2.73M6.24M4.89M8.91M16.73M52.97M193.52M189.37M234.17M268.74M204.00M260.89M
Gross Margin7.58%17.95%26.84%41.62%33.32%45.05%50.59%64.72%59.18%60.00%68.01%59.46%54.90%
Operating Expense85.38M165.52M227.61M199.46M272.76M284.36M326.43M292.68M351.67M416.10M455.44M481.67M484.23M
Operating Income-83.36M-162.79M-221.37M-194.56M-263.85M-267.63M-273.46M-99.16M-162.31M-181.93M-186.70M-277.67M-223.33M
Operating Margin-313.15%-1071.91%-952.17%-1654.46%-986.13%-720.50%-261.20%-33.16%-50.73%-46.61%-47.25%-80.94%-47.00%
EBITDA-78.14M-155.68M-211.76M-180.61M-250.38M-251.00M-240.65M-55.56M-111.35M-125.41M-98.59M-197.95M-166.96M
EBITDA Margin-293.55%-1025.07%-910.84%-1535.82%-935.78%-675.72%-229.86%-18.58%-34.80%-32.13%-24.95%-57.70%-35.13%
Net Income-208.02M-71.17M-21.26M-135.88M-263.46M-268.31M-280.07M-103.50M-165.20M-184.73M-164.20M-260.81M-201.20M
Net Income Margin-781.47%-468.64%-91.45%-1155.41%-984.68%-722.32%-267.52%-34.61%-51.63%-47.33%-41.55%-76.02%-42.34%
R&D59.61M133.15M191.01M137.88M204.54M195.71M216.97M197.00M205.85M238.37M246.00M272.62M298.59M
R&D as % of Total Revenue223.94%876.72%821.58%1172.42%764.48%526.88%207.24%65.88%64.34%61.07%62.25%79.46%62.83%
Interest Expense125.91M86.70M198.71M49.89M412.00K653.00K6.59M4.31M2.87M2.78M2.17M1.43M1.59M
Interest Expense % of Total Revenue473.00%570.86%854.69%424.23%1.54%1.76%6.29%1.44%0.90%0.71%0.55%0.42%0.33%

Balance Sheet

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets262.99M194.56M354.66M310.99M478.77M336.83M514.07M719.01M1.23B1.02B1.21B993.21M1.21B1.01B
Total Liabilities20.00M23.63M38.97M40.67M51.17M60.30M81.35M188.36M140.23M116.01M396.38M332.22M336.07M369.49M
Total Equity243.00M170.93M315.69M270.32M427.60M276.52M432.73M530.65M1.09B902.96M816.07M660.99M878.83M643.21M
Cash140.54M40.78M202.66M134.94M55.37M247.18M349.03M302.68M847.91M646.07M831.32M413.19M605.96M464.79M
Total Debt------8.50M134.70M61.43M58.76M49.11M34.43M19.52M59.56M
Net Debt-140.54M-40.78M-202.66M-134.94M-55.37M-247.18M-340.52M-167.98M-786.48M-587.31M-782.21M-378.76M-586.43M-405.23M

Cash Flow

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-91.93M-128.80M-209.24M-448.96M-250.36M-286.71M-313.84M-146.74M-151.77M145.87M-205.09M-207.74M-226.64M
Investing Cash Flow-12.64M-5.80M-28.84M-5.46M327.08M-23.89M-146.27M86.56M-16.39M-22.14M-198.02M-59.09M127.60M
Financing Cash Flow-279.24M158.08M407.16M140.39M407.67M439.24M656.76M-14.19M-14.86M-15.70M424.40M-18.81M
Capital Expenditure12.64M5.83M28.84M5.46M5.67M18.63M24.34M27.95M16.27M22.14M6.39M7.38M8.82M
Free Cash Flow-104.57M-134.63M-238.08M-454.43M-256.03M-305.34M-338.18M-174.69M-168.04M123.73M-211.48M-215.12M-235.46M
FCF to OCF113.75%104.52%113.78%101.22%102.26%106.50%107.76%119.05%110.72%84.82%103.12%103.55%103.89%

Earnings

Report DateAug 14, 2020Nov 12, 2020Mar 17, 2021May 13, 2021Aug 25, 2021Nov 11, 2021Mar 28, 2022May 10, 2022Sep 1, 2022Nov 10, 2022Mar 21, 2023May 12, 2023May 14, 2024Aug 22, 2024Nov 13, 2024Mar 13, 2025Aug 26, 2025Nov 11, 2025Mar 12, 2026
EPS Estimate--0.140.06-0.020.650.23-0.68----0.45--0.45-0.55-0.44--0.43-0.43-0.48
EPS Actual-1.11-0.280.65-0.29-0.67-0.75-0.31-0.90-0.39-0.54-0.43-0.62-0.77-0.61-0.80-0.78-0.66-0.33-0.63
Surprise--100.00%983.33%-1350.00%-203.08%-426.09%54.41%---4.44%--71.11%-10.91%-81.82%--53.49%23.26%-31.25%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.80B
Enterprise Value2.33B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.20
Price / Book4.05
EPS-0.48
Book Value6.82
Revenue (TTM)666.54M
Gross Profit (TTM)415.04M
EBITDA-28.09M
Profit Margin-7.34%
Operating Margin11.94%
Return on Equity-6.93%
Return on Assets-3.87%
Shares Outstanding102.82M
Shares Float71.37M
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%